<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Poster 3.9: Novel Uses for PDX Models in Preclinical Drug Development

Cancers are diverse genetic and immunological abnormalities, which results in specific treatments only being effective for small subsets of patients.